Mylan CEO Heather Bresch says the EpiPen price increase was necessary but the company will offer a $300 generic option Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback